BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Geneos Therapeutics Secures $5 Million in Series A3 Financing

  Geneos Therapeutics today announced that it has secured $5 million in its Series A3 round.

  April 12, 2023

   · 

  4 min read
• Biotech Bay

  Freenome Adds University of Chicago as a Partner for Its Vallania Study

  Freenome, a privately held biotech company, announced that the Institute for Population and Precision Health at the University of Chicago has joined as a study partner for its Vallania Study.

  April 12, 2023

   · 

  3 min read
• Business

  Amneal to Report First Quarter 2023 Results on May 5, 2023

  Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its first quarter 2023 financial results on Friday May 5, 2023, prior to market open.

  April 12, 2023

   · 

  1 min read
• Genetown

  Caraway Therapeutics to Present at 22nd Annual Needham Healthcare Conference

  Caraway Therapeutics today announced that the Company will be participating in the 22nd Annual Needham Healthcare Conference, taking place April 17-20, 2023.

  April 12, 2023

   · 

  1 min read
• Deals

  Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 12, 2023

  Scholar Rock today announced that the Company granted inducement equity awards covering an aggregate of 83,125 shares of its common stock to five newly hired employees, consisting of inducement stock options to purchase an aggregate of 47,500 shares of common stock.

  April 12, 2023

   · 

  3 min read
• Business

  BIOVAXYS ANNOUNCES APPOINTMENT OF CFO AND BOARD CHANGES

  BioVaxys Technology Corp. is pleased to announce that Dasha Enenko has been appointed as its Chief Financial Officer (“CFO”).

  April 12, 2023

   · 

  5 min read
• Business

  Outset Medical to Report First Quarter 2023 Financial Results on Wednesday, May 3, 2023

  Outset Medical, Inc. today announced that it will release financial results for the first quarter of 2023 after the close of trading on Wednesday, May 3, 2023.

  April 12, 2023

   · 

  1 min read
• Business

  Mayo Clinic Collaborates with Naveris to Advance Precision Medicine in HPV-driven Head and Neck Cancer with NavDx in DART 2.0 Clinical Trial

  Naveris, Inc., a leader in molecular diagnostics for viral cancers, today announced the launch of the DART 2.0 prospective clinical trial (NCT05541016) by Mayo Clinic.

  April 12, 2023

   · 

  2 min read
• BioMidwest

  Cardio Diagnostics Holdings, Inc to Attend 22nd Annual AHOU Conference

  Cardio Diagnostics Holdings, Inc announced that it is participating and exhibiting at the 22nd Annual Association of Home Office Underwriters Conference, a premier event for the life insurance underwriting industry.

  April 12, 2023

   · 

  5 min read
• Pharm Country

  Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development

  Medidata, a Dassault Systèmes company, today announced that Launch Therapeutics selected Medidata AI Intelligent Trials to support its innovative approach to accelerating clinical trials of late-stage therapies.

  April 12, 2023

   · 

  3 min read